Soleno Therapeutics, Inc. (SLNO) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$38.66
Day's range
$40.37

Soleno Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/17/2026 8.08 M $374.07 M   1.00% 15.15%
JANUS HENDERSON GROUP PLC 02/17/2026 7.18 M $332.30 M   18.53% 13.46%
BLACKROCK, INC. 02/12/2026 3.87 M $179.26 M   10.86% 7.26%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 3.32 M $153.85 M   43.71% 6.23%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 3.32 M $153.66 M   -14.97% 6.22%
VANGUARD GROUP INC 01/29/2026 3.06 M $141.69 M   9.02% 5.74%
AVORO CAPITAL ADVISORS LLC 03/16/2026 2.90 M $134.27 M   12.50% 5.44%
STATE STREET CORP 02/13/2026 2.65 M $122.68 M   21.93% 4.97%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/13/2026 1.31 M $60.84 M   52.13% 2.46%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.24 M $57.24 M   26.18% 2.32%
COMMODORE CAPITAL LP 02/17/2026 1.20 M $55.56 M   -11.11% 2.25%
BRAIDWELL LP 02/17/2026 1.19 M $55.00 M   -7.34% 2.23%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.16 M $53.87 M   7.22% 2.18%
POLAR CAPITAL HOLDINGS PLC 02/17/2026 1.14 M $52.64 M   -4.55% 2.13%
WOODLINE PARTNERS LP 02/17/2026 1.11 M $51.48 M   310.50% 2.08%
DEEP TRACK CAPITAL, LP 02/13/2026 1.00 M $46.30 M   100.00% 1.88%
GOLDMAN SACHS GROUP INC 03/25/2026 913.05 K $42.27 M   64.38% 1.71%
VIVO CAPITAL, LLC 02/13/2026 894.91 K $41.43 M   -60.72% 1.68%
INVESCO LTD. 02/19/2026 875.02 K $40.51 M   -41.69% 1.64%
READYSTATE ASSET MANAGEMENT LP 02/17/2026 874.45 K $40.49 M   324.89% 1.64%
FRANKLIN RESOURCES INC 02/11/2026 823.96 K $38.15 M   -1.41% 1.55%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 624.13 K $28.90 M   13.35% 1.17%
BANK OF NEW YORK MELLON CORP 02/10/2026 621.81 K $28.79 M   -0.86% 1.17%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/17/2026 618.01 K $28.61 M   0.75% 1.16%
ARTIA GLOBAL PARTNERS LP 02/17/2026 533.70 K $24.71 M   -20.60% 1.00%
IKARIAN CAPITAL, LLC 02/18/2026 528.90 K $24.49 M   200.34% 0.99%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/13/2026 502.00 K $23.24 M   402.00% 0.94%
SQUAREPOINT OPS LLC 02/13/2026 468.65 K $21.70 M   579.66% 0.88%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/13/2026 449.85 K $20.82 M   60.49% 0.84%
EMERALD ADVISERS, LLC 02/09/2026 412.65 K $19.11 M   -34.27% 0.77%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 401.19 K $18.57 M   3.04% 0.75%
GREAT POINT PARTNERS LLC 02/17/2026 400.00 K $18.52 M   77.78% 0.75%
KINGDON CAPITAL MANAGEMENT, L.L.C. 02/17/2026 399.90 K $18.52 M   32.86% 0.75%
ASSENAGON ASSET MANAGEMENT S.A. 01/09/2026 384.17 K $17.79 M   100.00% 0.72%
NORTHERN TRUST CORP 02/17/2026 365.42 K $16.92 M   3.16% 0.69%
CATALIO CAPITAL MANAGEMENT, LP 02/17/2026 360.34 K $16.68 M   -13.84% 0.68%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 357.30 K $16.54 M   -15.19% 0.67%
CAPTION MANAGEMENT, LLC 02/17/2026 342.50 K $15.86 M   -66.29% 0.64%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 02/17/2026 325.00 K $15.05 M   100.00% 0.61%
CITADEL ADVISORS LLC 02/17/2026 308.83 K $14.30 M   -31.39% 0.58%
LOGOS GLOBAL MANAGEMENT LP 02/17/2026 300.00 K $13.89 M   100.00% 0.56%
MORGAN STANLEY 02/13/2026 287.64 K $13.32 M   73.44% 0.54%
ABRDN PLC 01/16/2026 287.46 K $13.31 M   100.00% 0.54%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 287.29 K $13.30 M   336.80% 0.54%
PENN CAPITAL MANAGEMENT COMPANY, LLC 02/09/2026 275.78 K $12.80 M   100.00% 0.52%
CITIGROUP INC 02/13/2026 255.40 K $11.83 M   710.79% 0.48%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 254.90 K $11.80 M   -36.54% 0.48%
PFM HEALTH SCIENCES, LP 02/17/2026 247.89 K $11.48 M   1.85% 0.46%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/17/2026 247.05 K $11.44 M   59.88% 0.46%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 244.36 K $11.31 M   1,425.52% 0.46%

Soleno Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 312 institutional investors and hedge funds held shares of Soleno Therapeutics Inc. The most heavily invested institutionals were:

Pictet Asset Management Holding SA: 616,217

abrdn plc: 287,456

Candriam S.C.A.: 281,620

Bank of New York Mellon Corp: 277,851

EMERALD ADVISERS, LLC: 274,138

UBS Group AG: 225,147

121.60% of Soleno Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 68.81 M shares in the last 24 months. This purchase volume represents approximately $2.74 B in transactions.